Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
Details for Australian Patent Application No. 2009274190 (hide)
International Classifications
Event Publications
17 February 2011 PCT application entered the National Phase
PCT publication WO2010/011566 Priority application(s): WO2010/011566
5 July 2012 Application Accepted
Published as AU-B-2009274190
4 October 2012 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.
18 October 2012 Application for Amendment
The nature of the amendment is: Amend the name of the inventor to read Harper, Steven; Summa, Vincenzo; Liverton, Nigel J. and McCauley, John A. . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2010
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser